Prostaglandin E1 Ethanolamide is primarily utilized in medical research and therapeutic applications due to its role in modulating physiological processes. It is studied for its potential in managing inflammation, as it exhibits anti-inflammatory properties by influencing prostaglandin pathways. Additionally, it is explored for its neuroprotective effects, particularly in conditions like neurodegenerative diseases, where it may help reduce neuronal damage. In ophthalmology, it is investigated for its ability to regulate intraocular pressure, making it a candidate for glaucoma treatment. Furthermore, its vasodilatory effects are of interest in cardiovascular research, where it may aid in improving blood flow and reducing vascular resistance. Its application in pain management is also being examined, as it interacts with pain signaling pathways. Overall, this compound holds promise in diverse therapeutic areas due to its multifaceted biological activities.